Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance-Reference-Cited by-同舟云学术

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance

Published:2013-08-26 Issue:8 Volume:8 Page:e72680
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Billong Serge C.,Fokam Joseph,Aghokeng Avelin F.,Milenge Pascal,Kembou Etienne,Abessouguie Ibile,Meva’a-Onglene Flore Beatrice,Bissek Anne C. Zoung-Kanyi.,Colizzi Vittorio,Mpoudi Eitel N.,Elat Jean-Bosco N.,Shiro Koulla S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. UNAIDS (2012) Together we will end AIDS. WHO Library Cataloguing-in-Publication Data. www.unaids.org/…/unaids/…/jc2296_unaids_together_we_will_end_AIDS, accessed 15 October 2012.

2. New Delhi National AIDS Control Organisation (2012) National AIDS Control Programme Phase IV (2012–2017). http://www.nacoonline.org/NACP-IV, accessed 20 October 2012.

3. UNAIDS (2011) Political declaration on HIV and AIDS: intensifying our efforts to eliminate HIV and AIDS. http://www.unaids.org/en/aboutunaids/unitednationsdeclarationsandgoals/2011highlevelmeetingonaids, accessed 20 October 2012.

4. Kates J, Wexler A, Lief E, Gobet B (2011) Financing the response to AIDS in low- and middle-income countries: international assistance from donor governments in 2011. http://www.kff.org/hivaids/upload/7347-08.pdfhttp://www.kff.org/hivaids/upload/7347-08.pdf; accessed 15 October 2012.

5. Towards an improved investment approach for an effective response to HIV/AIDS;B Schwartländer;Lancet,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens;Viruses;2023-06-28

2. HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon;Medicine;2023-06-02

3. Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics;Medicine;2023-05-19

4. Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings;Microbiology Spectrum;2022-12-21

5. Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model;Viruses;2022-12-21